The Role of Business Process Outsourcing Firms During Adverse ...

Every pharmaceutical, biotech and device company has faced Adverse Events (AE) and Product Quality Complaints (PQC) daily. Depending on a number of factors, those issued may have been minor or garnered front-page news and endangered the company?s reputation. Nonetheless, as the industry faces increased regulations and competition, many have turned to Business Process Outsourcing (BPO) firms to help them overcome the challenges and problems surrounding AEs and PQCs.

All pharmaceutical, biotech and device companies are aware of the need to uphold the strictest standards of quality as outlined in the U.S. Food and Drug Administration?s (FDA) Code of Federal Regulations Title 21 and have a clear, strong governance for compliance expectations. Those companies that make use of BPOs, further ensure effortless compliance, process coverage and have the added benefits of unique input and counsel BPOs provide about how best to approach their business. Additionally, BPOs can provide benefit and scalability in reaching a large population and may be involved at many points in the lifecycle of a pharmaceutical, biotech or device product.

When BPOs Step In

In 2010, a U.S. manufacturer of pharmaceutical products began a voluntary recall of several over-the-counter products, after a routine FDA inspection found that the products did not meet required quality standards.

As the recall unfolded, many consumers who may have been affected could not get through to the company via phone due to the call volume. As companies have an ethical responsibility during the course of a recall to respond to all concerned customers, record every event and retrieve product as completely as possible, this manufacturer realized they needed more personnel, in addition to their current BPO, to handle consumer inquiries. With the call volume continuing to grow, additional BPOs were brought on to help, employing hundreds of specially trained individuals to more efficiently meet the recall requirements and stem consumer worries. The BPOs were also able to assist the company by maintaining their regular processing in addition to the recall.

As a result of the involvement of multiple BPO firms, the manufacturer was able to maintain customer satisfaction as well as their short-term and long-term reputation. Additionally the company was able to improve their ability to capture AEs and PQCs due to a much larger workforce dedicated to the task of recall management.

BPO Qualifications

The importance of properly trained and experienced BPO staff in the course of AE and PQC processing is crucial. Some companies mandate that much of the medical information be collected by a healthcare professional (normally a licensed nurse or pharmacist) whereas, others simply use individuals who hold four-year degrees, but may not necessarily be healthcare-related. Other companies may use one department or group for inquiries, AEs and PQCs altogether, while others yet may use dedicated staff for each circumstance.

There are many advantages of working with a qualified BPO; from experience with the type of event, familiarity and comfort-level with the reporting routines and content requirements, trained and experienced staff that is extremely comfortable in stressful and highly-regulated environments and most importantly the assistance of additional staff at a time when the event is driving call, email, etc. volume beyond normal capacities, all while keeping company costs low.

BPO exposure to various methods, systems and process across manufacturers enables them to develop a best-of-breed approach that can be customized in any situation and for any company. Additionally the right BPO is an industry leader which stays abreast of regulations, such as the currently forthcoming Health Information Technology for Economic and Clinical Health (HITECH) rules, allowing pharmaceutical, biotech and device companies to entrust them with tasks such as AE and PQC processing.

A good BPO partner will also have its own quality framework, which ensures accuracy of reporting and continual improvement through baseline expectations.? Some of the components include:

• Training ? Continually improving listening skills, product knowledge, AE/PQC regulations, and good documentation practices, among others.
• Case review ? If a BPO suspects that reported interactions may contain AEs or PQCs, the cases are placed in a queue for review by a second individual prior to submission.
• Quality Monitoring ? Occurring after an alleged event is reported, but allows for review of the actual interaction with the reporting party (via an audio recording).

BPOs and Event Reporting

The role of BPOs extends long after the AE or PQC event has been recorded and, if necessary, reported to the FDA.? Specifically, the Source Documentation and Quality Monitoring recordings, which must be retained as part of the file, might remain in the possession of the BPO. ?Each pharmaceutical, biotech and device manufacturer may also set their own rules about the length of retention time in addition to FDA expectations, and in some cases, that timeframe tends to be longer than what is required. Companies also differ in regards to reporting of events and the necessary related documentation. Specifically, each manufacturer will train their employees using certain examples or types of AEs or PQCs in order to prepare for the real-life event, but because companies cannot train for every possible eventuality, some manufacturers may subscribe to the ?when in doubt, report it? theory. In this case, BPOs can provide a case review after intake and help decide if the manufacturer may require further action.

Once a company reports a case, it is important to determine its classification (especially with PQCs) and investigation. Although there are no standard PQC classifications currently in place, there are basic requirements for a Quality System and its complaint reporting outlined in 21 CFR. Miss-classification can result in an oversight of a real and serious manufacturing issue because the quality of a product is only as good as the proper processing through the whole life of the product.

Since Quality Systems are designed to ensure the manufacturing and packaging of pharmaceutical, biotech and device products, manufacturers who fail in the responsibility and authority to self-monitor these factors will experience FDA-mandated product recalls. In addition to recalls, the FDA can enforce the following actions:

• Warning Letters ? for flagrant or continual violations
• Consent Decrees ? Use of third party consultants to remediate, fines for not meeting agreed upon timetables
• Judicial Actions ? Including seizures, injunctions and criminal prosecution

These enforcement actions have caused some firms millions of dollars in fines and lost revenue from having to suspend production at problem facilities

Why BPOs?

As outlined above, one of the most important roles of a BPO is to manage AE and PQC processing and improve efficiency in other core areas of pharmaceutical, biotech or device company?s business including data management and analytics. With more and more companies realizing the benefits and moving towards the use of a BPO for one reason or another, they are able to put more resources and efforts toward investigation, process validation, Annual Product Review, and training.

Source: http://www.pharmacompliancemonitor.com/the-role-of-business-process-outsourcing-firms-during-adverse-events-and-product-quality-complaints/3238/?utm_source=rss&utm_medium=rss&utm_campaign=the-role-of-business-process-outsourcing-firms-during-adverse-events-and-product-quality-complaints

google stock gawker hayden panettiere china gdp dont trust the b in apartment 23 johnny damon kirk cameron